1 / 41

Vascular Disturbances III Infarction & Shock

Vascular Disturbances III Infarction & Shock. Infarction. Infarction. Tissue necrosis due to ischaemia vascular insufficiency of any cause usually arterial occlusion due to thrombosis/embolism Mainly due to oxygen deficiency, but toxin accumulation & reperfusion injury may contribute

rpreciado
Download Presentation

Vascular Disturbances III Infarction & Shock

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Vascular Disturbances III Infarction & Shock

  2. Infarction

  3. Infarction • Tissue necrosis due to ischaemia • vascular insufficiency of any cause • usually arterial occlusion due to thrombosis/embolism • Mainly due to oxygen deficiency, but toxin accumulation & reperfusion injury may contribute • Number of determining factors • Size of vessel and size of vascular territory • Partial / total vascular occlusion • Duration of ischaemia

  4. Appearance of Infarct • Wedge-shaped • Occluded vessel at apex • Periphery of organ forms base • If extends to serosal surface, often overlying fibrinous exudate • Lateral margins blurred due to collateral blood supply

  5. Appearance of Infarct NORMAL TISSUE ARTERY SURFACE FIBRINOUS EXUDATE INFARCTED TISSUE OCCLUSION ILL-DEFINED INFARCT BORDERS

  6. Types of Infarct • Red (haemorrhagic) infarcts • Venous occlusion/congestion e.g. torsion • Loose tissues where haemorrhage can occur and blood can collect in infarcted zone e.g. lung • Tissues with dual blood supply e.g. lung small intestine (permitting blood flow from unobstructed vessel into infarcted zone – note flow is insufficient to rescue ischaemia) • Tissues that were previously congested due to sluggish venous outflow • When flow is re-established e.g. fragmentation of an occlusive embolus, angioplasty • White infarcts • arterial occlusion • solid tissues, where haemorrhage limited e.g. spleen, heart, kidney

  7. Types of Infarct Red pulmonary infarcts - dual pulmonary / bronchial arterial supply

  8. Types of Infarct White splenic infarct

  9. Event Sequence • Coagulative necrosis • Infiltration by neutrophils • Infiltration by macrophages • Phagocytosis of debris • Granulation tissue formation • Scar formation

  10. Event Sequence Day 1 3 7 14 90

  11. Infarct, day 0 Fibre eosinophilia & contraction band necrosis

  12. Infarct, day 1 Haemorrhage, necrosis and early neutrophil infiltrate

  13. Infarct, day 3 Myocyte necrosis, pyknosis and marked neutrophil infiltrate

  14. Infarct, day 7 Yellow necrotic infarct with hyperaemic border

  15. Infarct, day 10 Granulation tissue after macrophage phagocytosis of infarcted cells

  16. Infarct, day 90+ Subendocardial acellular fibrous scar

  17. Infarct Development • Dependent on a number of factors • Nature of vascular supply • Dual supply e.g. lungs, liver • End arteries e.g. kidneys, spleen • Rate of vascular occlusion • Time for development of collateral circulation • Vulnerability to hypoxia • Neurons – 2-3mins, Myocardium – 20-30mins, Fibroblasts – hours. • Oxygen content of blood • Anaemia, cyanosis, congestive heart failure • Can result in infarction due to otherwise inconsequential blockage • Size of vessel and size of vascular territory • Partial / total vascular occlusion • Duration of ischaemia

  18. Reperfusion Injury • Possible effects of re-establishing blood flow: • prevention of all necrosis • salvage of reversibly injured cells • accentuation of damage to irreversibly injured cells • new cellular damage • Latter two constitute reperfusion injury • Accentuated or new damage due to re-establishing blood flow • Many effects of ischaemic injury only seen when perfusion re-established

  19. Reperfusion Injury • Can result in accelerated transition through stages of infarct development • Timing of infarcts unreliable post reperfusion • Inevitable if reperfusion occurs after optimum salvage time e.g. usually 6 hours after myocardial infarct • Characterised histologically by: • Marked haemorrhage • Marked contraction band necrosis

  20. Reperfusion Injury • Causes: • delivery of oxygen and calcium ions to damaged tissue • interior of cells with damaged cell membranes exposed to high Ca++ conc  cell lysis • generation of oxygen-dependent free radicals by damaged cells and phagocytes  cell lysis • accentuation of O2-dependent damage • Anti-oxidants have only small effect on tissue loss • Acceleration of damage to irreversibly damaged cells more than new cellular damage

  21. Shock

  22. Shock (cardiovascular collapse) • Final Common Pathway for a umber of potentially lethal clinical events: • Severe Haemorrhage • Burns • Trauma • Large MI • (massive) Pulmonary Embolism • Microbial Sepsis

  23. Shock (cardiovascular collapse) • Circulatory failure resulting in inadequate tissue perfusion (systemic hypoperfusion) • Results in: • hypotension • impaired tissue perfusion • cellular hypoxia • reversible cellular injury • irreversible cell injury and cell death

  24. Types of Shock • Cardiogenic - due to myocardial pump failure • Intrinsic damage (MI) • Ventricular arrhythmias • Extrinsic compression (Tamponade) • Outflow obstruction (e.g. pulmonary embolism) • Hypovolaemic - due toloss of blood or plasma volume • Haemorrhage • Fluid Loss from severe burns • Trauma

  25. Septic Systemic microbial infection Neurogenic Loss of vascular tone – spinal cord injury Anaphylactic Generalised IgE hypersensitivity response- systemic vasodilation - due to reduction in effective circulating blood volume peripheral pooling secondary to vasodilation and leakage of fluid due to increased vascular permeability

  26. Types of Shock • Cardiogenic • myocardial pump failure • e.g. myocardial infarction, ventricular rupture, ventricular arrhythmia, cardiac tamponade, pulmonary embolism • Hypovolaemic • loss of blood or plasma volume • e.g. haemorrhage, trauma, burns, vomiting, diarrhoea

  27. Types of Shock • Neurogenic shock • peripheral pooling of blood due to loss of vascular tone • e.g. anaesthetic accident / spinal cord injury • Anaphylactic shock • systemic IgE-mediated hypersensitivity reaction to allergens e.g. bee stings, peanut • release of mast cell mediators • systemic vasodilation and increased vascular permeability

  28. Types of Shock • Septic shock • overwhelming microbial infection • gram negative sepsis • due to lipopolysaccharide (LPS / endotoxin) in walls • gram-positive / fungal septicaemia • due to molecules similar to LPS in walls • Super-antigen release

  29. Septic Shock • Usually due to lipopolysaccharide (LPS/endotoxin) in walls of gram negative bacteria • LPS consists of fatty acid core and complex carbohydrate coat • Similar molecules in walls of gram positive bacteria or fungi • results in • endothelial damage • complement activation • activation of macrophages with cytokine release

  30. Event Sequence • Low doses: • Local effectsof LPS & primary mediators (IL-1, TNF) • Complement activation by LPS • Monocyte/macrophage activation by LPS • binding to surface receptors • production of low doses of IL-1 and TNF • Endothelial cell activation by IL-1 & TNF • production of IL-6 & 8 by endothelium • increased adhesion molecule expression • Recruitment of inflammatory cells and cytokine cascade

  31. Event Sequence • Intermediate doses: • Local effects of LPS & secondary mediators (NO, PAF) • Systemic effects of primary mediators (IL-1, TNF) • Endothelial cell injury by LPS • triggering of coagulation cascade • increased vascular permeability • production of secondary mediators by endothelium • Local vasodilation due to secondary mediators: nitric oxide, platelet activating factor • Systemic effects of IL-1 and TNF • Fever • Acute-phase reactant production (CRP, fibrinogen)

  32. Event Sequence • High doses • Systemic effects of LPS, primary & secondary mediators • Widespread endothelial cell injury (LPS, cytokines) • Acute respiratory distress syndrome • Widespread activation of coagulation (LPS, cytokines) • Disseminated intravascular coagulation • Peripheral vasodilation, decreased cardiac contractility (NO) • Hypotension • Multiorgan failure due to hypoperfusion

  33. Multiorgan Failure • Multiple organ damage due to ischaemia secondary to hypoperfusion • brain: ischaemic encephalopathy • heart: subendocardial infarcts • kidney: acute tubular necrosis • GIT: haemorrhagic enteropathy / ischaemia • liver: fatty change / centrilobular haemorrhagic necrosis • ARDS in lungs commonly present concurrently • Due to microvascular injury, not ischaemia

  34. Stages of Shock • Nonprogressive phase • Reflex compensatory mechanisms maintain perfusion of vital organs • Tachycardia, peripheral vasoconstriction (pale cold clammy skin), renal conservation of fluid (anuria) • Progressive phase • Tissue hypoperfusion & metabolic imbalance • Development of acidosis • Due to anaerobic glycolysis and renal failure • Causes arteriolar dilatation and peripheral pooling of blood • Worsens hypotension and exacerbates tissue ischaemia • Irreversible phase • Irreversible cellular and tissue injury • No response even if haemodynamic defects corrected

  35. Consequences of Shock Pink hyaline membranes lining alveolar spaces in ARDS

  36. Consequences of Shock ATN – swollen, sloughed and flattened regenerating tubular epithelium, normal glomerulus Normal glomerulus and tubules

  37. Consequences of Shock • Prognosis varies with cause and duration • If circulatory disturbance corrected during nonprogressive phase  full recovery • If progress to irreversible phase  high mortality • Hypovolaemic shock • > 80 – 90% survival in young healthy adults (10 - 20% mortality) • Cardiogenic shock due to MI / Septic shock • up to 75% mortality even with appropriate management

  38. Summary • Infarction • Definition • Infarct Types • Timing of Infarcts • Reperfusion injury • Shock • Types of shock and aetiology • Stages of shock • Consequences

  39. بزرگترین بانک پاورپوینت ایرانwww.txtzoom.comبانک هوشمند اسناد متنی

More Related